Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Normal muscle regeneration requires tight control of muscle cell fusion by tetraspanins CD9 and CD81.

Charrin S, Latil M, Soave S, Polesskaya A, Chrétien F, Boucheix C, Rubinstein E.

Nat Commun. 2013;4:1674. doi: 10.1038/ncomms2675.

PMID:
23575678
2.

Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes.

Takeda Y, Tachibana I, Miyado K, Kobayashi M, Miyazaki T, Funakoshi T, Kimura H, Yamane H, Saito Y, Goto H, Yoneda T, Yoshida M, Kumagai T, Osaki T, Hayashi S, Kawase I, Mekada E.

J Cell Biol. 2003 Jun 9;161(5):945-56.

3.
4.
5.

Distinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells.

Parthasarathy V, Martin F, Higginbottom A, Murray H, Moseley GW, Read RC, Mal G, Hulme R, Monk PN, Partridge LJ.

Immunology. 2009 Jun;127(2):237-48. doi: 10.1111/j.1365-2567.2008.02945.x.

6.

The Ig domain protein CD9P-1 down-regulates CD81 ability to support Plasmodium yoelii infection.

Charrin S, Yalaoui S, Bartosch B, Cocquerel L, Franetich JF, Boucheix C, Mazier D, Rubinstein E, Silvie O.

J Biol Chem. 2009 Nov 13;284(46):31572-8. doi: 10.1074/jbc.M109.057927.

7.

EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily.

Stipp CS, Kolesnikova TV, Hemler ME.

J Biol Chem. 2001 Nov 2;276(44):40545-54.

8.

Laminin alpha4 and integrin alpha6 are upregulated in regenerating dy/dy skeletal muscle: comparative expression of laminin and integrin isoforms in muscles regenerating after crush injury.

Sorokin LM, Maley MA, Moch H, von der Mark H, von der Mark K, Cadalbert L, Karosi S, Davies MJ, McGeachie JK, Grounds MD.

Exp Cell Res. 2000 May 1;256(2):500-14.

PMID:
10772822
9.

Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro.

Iwasaki T, Takeda Y, Maruyama K, Yokosaki Y, Tsujino K, Tetsumoto S, Kuhara H, Nakanishi K, Otani Y, Jin Y, Kohmo S, Hirata H, Takahashi R, Suzuki M, Inoue K, Nagatomo I, Goya S, Kijima T, Kumagai T, Tachibana I, Kawase I, Kumanogoh A.

J Biol Chem. 2013 Jan 25;288(4):2118-31. doi: 10.1074/jbc.M112.424291.

10.

In situ chemical cross-linking on living cells reveals CD9P-1 cis-oligomer at cell surface.

André M, Chambrion C, Charrin S, Soave S, Chaker J, Boucheix C, Rubinstein E, Le Naour F.

J Proteomics. 2009 Nov 2;73(1):93-102. doi: 10.1016/j.jprot.2009.08.005.

PMID:
19703604
11.

Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice.

Takeda Y, He P, Tachibana I, Zhou B, Miyado K, Kaneko H, Suzuki M, Minami S, Iwasaki T, Goya S, Kijima T, Kumagai T, Yoshida M, Osaki T, Komori T, Mekada E, Kawase I.

J Biol Chem. 2008 Sep 19;283(38):26089-97. doi: 10.1074/jbc.M801902200.

12.
13.

Normal myoblast fusion requires myoferlin.

Doherty KR, Cave A, Davis DB, Delmonte AJ, Posey A, Earley JU, Hadhazy M, McNally EM.

Development. 2005 Dec;132(24):5565-75.

14.

Statins decrease lung inflammation in mice by upregulating tetraspanin CD9 in macrophages.

Jin Y, Tachibana I, Takeda Y, He P, Kang S, Suzuki M, Kuhara H, Tetsumoto S, Tsujino K, Minami T, Iwasaki T, Nakanishi K, Kohmo S, Hirata H, Takahashi R, Inoue K, Nagatomo I, Kida H, Kijima T, Ito M, Saya H, Kumanogoh A.

PLoS One. 2013 Sep 9;8(9):e73706. doi: 10.1371/journal.pone.0073706.

15.

The tetraspanins CD9 and CD81 regulate CD9P1-induced effects on cell migration.

Chambrion C, Le Naour F.

PLoS One. 2010 Jun 21;5(6):e11219. doi: 10.1371/journal.pone.0011219.

16.

Adhesion proteins--an impact on skeletal myoblast differentiation.

Przewoźniak M, Czaplicka I, Czerwińska AM, Markowska-Zagrajek A, Moraczewski J, Stremińska W, Jańczyk-Ilach K, Ciemerych MA, Brzoska E.

PLoS One. 2013 May 6;8(5):e61760. doi: 10.1371/journal.pone.0061760.

17.

Reduced fertility of female mice lacking CD81.

Rubinstein E, Ziyyat A, Prenant M, Wrobel E, Wolf JP, Levy S, Le Naour F, Boucheix C.

Dev Biol. 2006 Feb 15;290(2):351-8.

18.

A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth.

Colin S, Guilmain W, Creoff E, Schneider C, Steverlynck C, Bongaerts M, Legrand E, Vannier JP, Muraine M, Vasse M, Al-Mahmood S.

Br J Cancer. 2011 Sep 27;105(7):1002-11. doi: 10.1038/bjc.2011.303.

19.

Distinct regions of the large extracellular domain of tetraspanin CD9 are involved in the control of human multinucleated giant cell formation.

Hulme RS, Higginbottom A, Palmer J, Partridge LJ, Monk PN.

PLoS One. 2014 Dec 31;9(12):e116289. doi: 10.1371/journal.pone.0116289.

20.

Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection.

Montpellier C, Tews BA, Poitrimole J, Rocha-Perugini V, D'Arienzo V, Potel J, Zhang XA, Rubinstein E, Dubuisson J, Cocquerel L.

J Biol Chem. 2011 Apr 22;286(16):13954-65. doi: 10.1074/jbc.M111.220103.

Supplemental Content

Support Center